Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?
Authors Cai H, Liu W, Liu X, Li Z, Feng T, Xue Y, Liu Y
Received 31 January 2020
Accepted for publication 5 May 2020
Published 21 May 2020 Volume 2020:13 Pages 4473—4483
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Leo Jen-Liang Su
Heng Cai,1– 3,* Wenjing Liu,4,* Xiaobai Liu,1– 3 Zhiqing Li,1– 3 Tianda Feng,1– 3 Yixue Xue,5 Yunhui Liu1– 3
1Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang 110004, People’s Republic of China; 2Liaoning Clinical Medical Research Center in Nervous System Disease, Shenyang 110004, People’s Republic of China; 3Key Laboratory of Neuro-Oncology in Liaoning Province, Shenyang 110004, People’s Republic of China; 4Department of Geriatrics, First Hospital of China Medical University, Shenyang 110001, People’s Republic of China; 5Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang 110122, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yunhui Liu Email email@example.com
Abstract: Vasculogenic mimicry (VM) is the formation of a “vessel-like” structure without endothelial cells. VM exists in vascular-dependent solid tumors and is a special blood supply source involved in the highly invasive tumor progression. VM is observed in a variety of human malignant tumors and is closely related to tumor proliferation, invasion, and recurrence. Here, we review the mechanism, related signaling pathways, and molecular regulation of VM in glioma and discuss current research problems and the potential future applications of VM in glioma treatment. This review may provide a new viewpoint for glioma therapy.
Keywords: glioma, vasculogenic mimicry, glioma stem cells, hypoxia, drug delivery systems, noncoding RNAs
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]